資源描述：
《冠心病高黏滯血癥患者應(yīng)用紅花黃色素氯化鈉治療的臨床效果分析-論文.pdf》由會(huì)員上傳分享，免費(fèi)在線(xiàn)閱讀，更多相關(guān)內(nèi)容在行業(yè)資料-天天文庫(kù)。
1、中醫(yī)中藥China&ForeignMsdtoalTreatment口——幽躅■__冠心病高黏滯血癥患者應(yīng)用紅花黃色素氯化鈉治療的臨床效果分析田曉華魏琴河南省新鄉(xiāng)市第一人民醫(yī)院藥劑科。河南新鄉(xiāng)453000【摘要】目的分析冠心病高黏滯血癥患者采用紅花黃色素氯化鈉治療的臨床效果。方法選擇該院2013年7月一2014年7月收治的冠心病高黏滯血癥患者50例，將其隨機(jī)分成實(shí)驗(yàn)組和對(duì)照組各25例，對(duì)照組患者給予常規(guī)治療，實(shí)驗(yàn)組患者在常規(guī)治療的基礎(chǔ)上給予紅花黃色素氯化鈉治療。對(duì)兩組患者的臨床治療效果和治療前后的血液流變學(xué)指標(biāo)變化情況進(jìn)行比較分析。結(jié)果實(shí)驗(yàn)組
2、患者的臨床治療有效率高于對(duì)照組患者的臨床治療有效率，但是兩組比較差異無(wú)統(tǒng)計(jì)學(xué)意義(戶(hù)>0．05)；兩組患者中，除對(duì)照組患者的全血還原粘度無(wú)明顯變化外，兩組其余各項(xiàng)血液流變學(xué)指標(biāo)均顯著低于治療前(0．05)；治療后，兩組患者除纖維蛋白原含量和紅細(xì)胞積壓指標(biāo)比較差異無(wú)統(tǒng)計(jì)學(xué)意義(P>0．05)，其余各項(xiàng)指標(biāo)比較差異均有統(tǒng)計(jì)學(xué)意義(I<0．05)。結(jié)論在冠心病高黏滯血癥患者的治療中，應(yīng)用紅花黃色素氯化鈉能取得比較理想的治療效果?！娟P(guān)鍵詞】冠心痛高黏滯血癥；紅花黃色素氯化鈉；臨床效果【中圖分類(lèi)號(hào)】R541．4【文獻(xiàn)標(biāo)識(shí)碼】A【文章編號(hào)】1674—0
3、742(2015)02(b)-0168—03AnalysisoftheclinicaleffectofcoronaryheartdiseasewithhyperviscositysyndromeinpatientswithapplicationofsafioryellowandsodiumchloridetreatmentTIANXiaohuaWEIQinHenanprovinceXinxiangFimtPeoplesHospitalpharmacy，Xinxiang，HenanProvince，453000，China[Abstract]
4、ObjectivetoanalyzeclinicalefectofcoronaryheartdiseasehJighviscositysodiumchloridetreatedbysatTloweryellowlaginpatientswith．Methodscoronaryheartdiseaseinourhospitalin2013Julytoselectthe2014Julywere50casesofpatientswithhighviscosityandplasma，dividedintotheexperimentalgroupan
5、dthecontrolgroupwith25casesineachgroup，thecontrolgroupweregivenroutinetreatment，patientsintheexperimentalgroupintheconventionaltreatmentbasedonthegivensaffloryel·lowsodiumchloridetreatment．Bloodrheologybeforeandafterthetwogroupsofpatientswithclinicalefectsandtreatmentoflea
6、rningindicatorsofchangesincomparativeanalysis．Resultstheclinicaltreatmentoftheexperimentalgroupwerehigherthanthatinthecontrolgrouptheefectiverateofclinicaltreatmentinpatientswitheficiency，butthediferencebetweenthetwogroupshadnostatisticalsignificance>O．O5)；twopatientsincon
7、trolgroup，thewholebloodreductionviscosityinpatientswithnoobviouschange，twogroupsoftherestofthebloodrheologyindicesweresignificantlylowerthanthatofbeforetreatment<0．05)；aftertreatment，twogroupsofpatientsinadditiontothecontentoffibfinogenanderythrocytebacklogindexhavenosigni
8、fi·cantdiference(尸>0．05)，therestoftheindexdiferencewasstatisticallysignificant<0．05)．Conc
